Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Long-term Follow-up Study of Patients Who Received EG110A, a Non-replicative Herpes Simplex Virus 1-derived Gene TherapyFemale Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, Male Urogenital Diseases, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urogenital Diseases, Urological Manifestations, central nervous system disorder, injury, nervous system disorder, nervous system injury, overactive bladder, spinal cord disorder, spinal cord injury, urinary bladder disorder, urinary system disorderNot yet recruitingPhase 1 / Phase 22025-11-12NCT07227285

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Cyllene Therapeutics2

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Rancho Los Amigos National Rehabilitation CenterDowneyUnited States10
Sidney Kimmel Medical CollegePhiladelphiaUnited States2
University of Michigan Rogel Cancer CenterAnn ArborUnited States186
UTHealth Houston / TIRR Memorial HermannHoustonUnited States2